Sara restrepo (3)
•Download as PPT, PDF•
1 like•244 views
The document discusses two scientific articles: 1) ProteinSimple introduced the Simple Western system, which automates and simplifies the traditional Western blot technique for protein analysis. The Simple Western eliminates messy gels and manual processing, allowing experiments to be completed in hours rather than days. 2) Researchers developed a new simplified method for producing adeno-associated viral vectors for gene therapy that requires only a single cloning step compared to previous multiple-step methods. This faster approach could help advance gene therapy research and commercialization.
Report
Share
Report
Share
Recommended
Whole Genome Sequencing (WGS) for surveillance of foodborne infections in Den...
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Applications of WGS for surveillance of foodborne infections in Denmark; benefits and potential drawbacks on performance and cost. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management -23-25 May 2016, Rome, Italy.
How HoloLens Transforms Healthcare
Slides from my talk at Microsoft Reactor @ Grand Central Tech on 1/11 on how we use Microsoft HoloLens at Weill Cornell Medicine to Transform Healthcare.
In this talk we cover key topics in Healthcare such as big data, genomics, precision medicine and cancer research and how they can benefit from novel data visualization methods such as HoloLens, Occulus Rift, Google Glass, etc.
Event Details: http://microsoftreactor.com/event/hololens-transforms-healthcare/
Meetup Page: https://www.meetup.com/NYC-HoloLens-Developers-Meetup/events/236085063/
dkNET Webinar "YCharOS: Antibody Characterization Through Open Science" 10/22...
Abstract
Many (most!) genes/proteins linked to disease phenotypes remain severely understudied [1]. Distinct open-science initiatives are needed to promote the exploration of currently understudied proteins, from the proper identification of research reagents [2], to the development of a chemical probes for every human protein [1]. We focus on the proper characterization of antibodies to guide researchers in selecting the most specific/selective antibodies for their needed application(s) [3].
Antibodies are among the most commonly used reagents in cell biology. Generally, scientists purchase antibodies from commercial suppliers, and rely on the vendor’s quality control data to make their purchasing decisions. While there are many outstanding commercially-available antibodies, many other antibodies do not perform as advertised - and in the absence of an objective means to compare performance, it is impossible to tell one from the other. This is a widely known problem that plagues tens of thousands of scientists annually [4-6].
There is a scientific solution, enabled by CRISPR/Cas9 technology. By comparing signals from wild-type and isogenic knockout cells, one can readily test the specificity of antibodies. We applied this approach in a pilot study demonstrating that only three of the 16 commercially-available antibodies for C9ORF72, the protein product of a major amyotrophic lateral sclerosis disease locus, specifically recognized the protein. Distressingly, neither antibody had been used in a publication, and the antibody used most frequently in publications, which have been cited thousands of times, did not recognize the protein in any application [7].
We are now applying our antibody characterization pipeline to generate head-to-head comparisons of commercial antibodies for all human proteins. This work is performed in partnership with high-quality manufacturers that provide in-kind reagents (i.e. antibodies and knock-out lines). Finalized antibody characterization reports are progressively uploaded on a free open-science repository (https://zenodo.org/communities/ycharos/). We believe our initiative, Antibody Characterization through Open Science (YCharOS), will contribute to make science more reproducible and help illuminate the dark genome.
The top 3 key questions that YCharOS can answer:
1. Do antibodies used in my field perform as advertised?
2. How do I identify the best performing antibody for my protein of interest?
3. Do I need to launch an expensive and time-consuming antibody generation study or do effective commercial antibodies already exist for my protein of interest?
References (see https://dknet.org/about/blog/2334)
Presenter: Carl Laflamme, PhD, Senior Postdoctoral Fellow at the Montreal Neurological Institute (The Neuro, McGill University). Chetan Raina, YCharOS, CEO.
Upcoming webinars schedule: https://dknet.org/about/webinar
dkNET Webinar: Addgene, The Nonprofit Plasmid Repository 04/24/2020
Abstract
Addgene’s mission is to accelerate research and discovery by improving access to useful research materials and information. We facilitate the sharing of high-quality scientific materials, research reproducibility, and open science by archiving and distributing DNA-based research reagents and associated data to scientists worldwide. Our repository contains over 84,000 plasmids, including special collections on CRISPR and fluorescent proteins, and more than 450 ready-to-use AAV and lentiviral preparations. There is no cost for scientists to deposit plasmids, which saves time and money associated with shipping plasmids themselves. All plasmids in Addgene’s repository were deposited by your scientific colleagues from around the world. All plasmids are fully sequenced for validation and sequencing data is openly available. Furthermore, we offer free educational resources about molecular biology topics including the AAV Data Hub, our blog, eBooks, and written and video protocols.
The top 3 key questions that Addgene repository can answer:
1. How can I find relevant DNA-based reagents for studying my disease model of interest?
2. Which molecular biology tools and techniques are appropriate for my experiments?
3. What are the benefits of sharing my plasmids and how do I deposit plasmids into the repository?
Presenter: Dr. Angela Abitua, Outreach Scientist at Addgene, the nonprofit plasmid repository
dkNET Webinar Information: https://dknet.org/about/webinar
Added Value of Open data sharing using examples from GenomeTrakr
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Added Value of Open data sharing using examples from GenomeTrakr. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
Day 2: Intro to CLIMB at the MRC Unit, Gambia
This document introduces the nullarbor bioinformatics tool. It provides instructions on running nullarbor using test Campylobacter dataset isolates. The summary shows that nullarbor performs analysis including assembly, annotation, variant calling and phylogenetic trees on microbial sequencing data from multiple isolates. It finds one of the four test isolates was contaminated and another was passaged through a chicken based on differences observed in the nullarbor output.
Next-Generation Sequencing Commercial Milestones Infographic
Next-generation sequencing (NGS) has revolutionized the way we analyze diseases and commercial outfits such as Illumina, Helicos, QIAGEN and Pacific Biosciences have made significant contributions. In addition, the launch of direct-to-consumer genetic testing solutions has dramatically changed the way consumers access genomics data. Until a few years ago, the cost of sequencing was a major bottleneck. Recent developments have reduced the cost from thousands of dollars to a couple of cents per megabase. When did these changes start? What were the changes in the commercial sector in the last 15 years? This infographic is a timeline of the NGS commercial marketplace.
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infectio...
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
Recommended
Whole Genome Sequencing (WGS) for surveillance of foodborne infections in Den...
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Applications of WGS for surveillance of foodborne infections in Denmark; benefits and potential drawbacks on performance and cost. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management -23-25 May 2016, Rome, Italy.
How HoloLens Transforms Healthcare
Slides from my talk at Microsoft Reactor @ Grand Central Tech on 1/11 on how we use Microsoft HoloLens at Weill Cornell Medicine to Transform Healthcare.
In this talk we cover key topics in Healthcare such as big data, genomics, precision medicine and cancer research and how they can benefit from novel data visualization methods such as HoloLens, Occulus Rift, Google Glass, etc.
Event Details: http://microsoftreactor.com/event/hololens-transforms-healthcare/
Meetup Page: https://www.meetup.com/NYC-HoloLens-Developers-Meetup/events/236085063/
dkNET Webinar "YCharOS: Antibody Characterization Through Open Science" 10/22...
Abstract
Many (most!) genes/proteins linked to disease phenotypes remain severely understudied [1]. Distinct open-science initiatives are needed to promote the exploration of currently understudied proteins, from the proper identification of research reagents [2], to the development of a chemical probes for every human protein [1]. We focus on the proper characterization of antibodies to guide researchers in selecting the most specific/selective antibodies for their needed application(s) [3].
Antibodies are among the most commonly used reagents in cell biology. Generally, scientists purchase antibodies from commercial suppliers, and rely on the vendor’s quality control data to make their purchasing decisions. While there are many outstanding commercially-available antibodies, many other antibodies do not perform as advertised - and in the absence of an objective means to compare performance, it is impossible to tell one from the other. This is a widely known problem that plagues tens of thousands of scientists annually [4-6].
There is a scientific solution, enabled by CRISPR/Cas9 technology. By comparing signals from wild-type and isogenic knockout cells, one can readily test the specificity of antibodies. We applied this approach in a pilot study demonstrating that only three of the 16 commercially-available antibodies for C9ORF72, the protein product of a major amyotrophic lateral sclerosis disease locus, specifically recognized the protein. Distressingly, neither antibody had been used in a publication, and the antibody used most frequently in publications, which have been cited thousands of times, did not recognize the protein in any application [7].
We are now applying our antibody characterization pipeline to generate head-to-head comparisons of commercial antibodies for all human proteins. This work is performed in partnership with high-quality manufacturers that provide in-kind reagents (i.e. antibodies and knock-out lines). Finalized antibody characterization reports are progressively uploaded on a free open-science repository (https://zenodo.org/communities/ycharos/). We believe our initiative, Antibody Characterization through Open Science (YCharOS), will contribute to make science more reproducible and help illuminate the dark genome.
The top 3 key questions that YCharOS can answer:
1. Do antibodies used in my field perform as advertised?
2. How do I identify the best performing antibody for my protein of interest?
3. Do I need to launch an expensive and time-consuming antibody generation study or do effective commercial antibodies already exist for my protein of interest?
References (see https://dknet.org/about/blog/2334)
Presenter: Carl Laflamme, PhD, Senior Postdoctoral Fellow at the Montreal Neurological Institute (The Neuro, McGill University). Chetan Raina, YCharOS, CEO.
Upcoming webinars schedule: https://dknet.org/about/webinar
dkNET Webinar: Addgene, The Nonprofit Plasmid Repository 04/24/2020
Abstract
Addgene’s mission is to accelerate research and discovery by improving access to useful research materials and information. We facilitate the sharing of high-quality scientific materials, research reproducibility, and open science by archiving and distributing DNA-based research reagents and associated data to scientists worldwide. Our repository contains over 84,000 plasmids, including special collections on CRISPR and fluorescent proteins, and more than 450 ready-to-use AAV and lentiviral preparations. There is no cost for scientists to deposit plasmids, which saves time and money associated with shipping plasmids themselves. All plasmids in Addgene’s repository were deposited by your scientific colleagues from around the world. All plasmids are fully sequenced for validation and sequencing data is openly available. Furthermore, we offer free educational resources about molecular biology topics including the AAV Data Hub, our blog, eBooks, and written and video protocols.
The top 3 key questions that Addgene repository can answer:
1. How can I find relevant DNA-based reagents for studying my disease model of interest?
2. Which molecular biology tools and techniques are appropriate for my experiments?
3. What are the benefits of sharing my plasmids and how do I deposit plasmids into the repository?
Presenter: Dr. Angela Abitua, Outreach Scientist at Addgene, the nonprofit plasmid repository
dkNET Webinar Information: https://dknet.org/about/webinar
Added Value of Open data sharing using examples from GenomeTrakr
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Added Value of Open data sharing using examples from GenomeTrakr. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
Day 2: Intro to CLIMB at the MRC Unit, Gambia
This document introduces the nullarbor bioinformatics tool. It provides instructions on running nullarbor using test Campylobacter dataset isolates. The summary shows that nullarbor performs analysis including assembly, annotation, variant calling and phylogenetic trees on microbial sequencing data from multiple isolates. It finds one of the four test isolates was contaminated and another was passaged through a chicken based on differences observed in the nullarbor output.
Next-Generation Sequencing Commercial Milestones Infographic
Next-generation sequencing (NGS) has revolutionized the way we analyze diseases and commercial outfits such as Illumina, Helicos, QIAGEN and Pacific Biosciences have made significant contributions. In addition, the launch of direct-to-consumer genetic testing solutions has dramatically changed the way consumers access genomics data. Until a few years ago, the cost of sequencing was a major bottleneck. Recent developments have reduced the cost from thousands of dollars to a couple of cents per megabase. When did these changes start? What were the changes in the commercial sector in the last 15 years? This infographic is a timeline of the NGS commercial marketplace.
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infectio...
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
Bacterial Pathogen Genomics at NCBI
"Bacterial Pathogen Genomics at NCBI" presentation at the Standards for Pathogen Identification via NGS (SPIN) workshop hosted by National Institute for Standards and Technology October 2014 by Dr. Bill Klimke.
Viral ER Presentation (1)
This document summarizes a project aiming to decrease viral virulence through reverse evolution. The project will passage viruses multiple times in host cells expressing a viral protein to induce loss of function mutations. If viruses lose ability to produce the supplemented protein, they may become replication deficient. Experiments are examining influenza A virus passage in cells expressing the M1 protein over multiple generations to induce loss of function mutations through viral adaptation. Optimization of cell culture and molecular techniques like qPCR are improving the model. Future work will sequence evolved viruses to analyze genetic changes and their effects on function.
Oncomine Myeloid GX NGS Solution Infographic
The document summarizes the Oncomine Myeloid Assay GX, a one-day genomic profiling assay for myeloid samples. It provides automated specimen-to-report workflow including library preparation, sequencing, variant calling, and reporting. The assay can simultaneously interrogate DNA mutations and RNA fusion transcripts covering major myeloid disorders. It has high gene coverage, detects challenging targets, and provides an annotated variant report.
OS20 - Avidity ELISA provides a good correlate with the virus neutralization ...
The avidity ELISA provides a good correlate with the virus neutralization test in assessing vaccine-induced antibodies in buffaloes. The study developed a single dilution avidity ELISA to measure FMD vaccine antibodies in buffaloes and compared it to standard tests like virus neutralization tests and liquid phase blocking ELISA. Results showed substantial concordance between the avidity ELISA and virus neutralization test, while the liquid phase blocking ELISA only had moderate concordance. The avidity ELISA and virus neutralization test also similarly detected a decrease in antibody levels of calves with maternal antibodies, which was significantly different at specific time points post-vaccination. The avidity ELISA provides a simple, specific technique that could replace the virus neutralization test for monitoring vaccine
Application of Whole Genome Sequencing in the infectious disease’ in vitro di...
This document discusses the application of whole genome sequencing in infectious disease diagnostics. It provides examples of how genome sequencing has been used to identify bacterial species, detect antibiotic resistance genes, and study outbreaks. The document also discusses challenges around regulatory approval of genomic tests, data sharing policies, and database management. Overall, it argues that whole genome sequencing is a valuable tool but that standards must be developed to ensure high quality data.
Transgenic mice service
Since the first EGFR targeting antibody panitumumab (Vectibix) from humanized mice has obtained regulatory approval in 2005, dozens of additional transgenic mouse-derived mAbs have entered human clinical testing, i.e., CD20 (Ofatumumab), CD4 (Zanolimumab), CD70, etc. These genetically "humanized" animals have become one of the most powerful strategies for therapeutic/ diagnostic antibody development, which is now the fastest growing group of mAb drugs in clinical trials currently.
DGR Technology Platform for Engineering Proteins Advanced in Publication by A...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--AvidBiotics today announced the publication of new fin...
I Jornada Actualización en Genética Reproductiva y Fertilidad
Illumina is a global leader in genomic technologies that provides sequencing and microarray solutions. Their portfolio includes the MiSeq, NextSeq 500, HiSeq 2500, and HiSeq X Ten sequencing platforms. Illumina serves customers in human health, research, reproductive health, forensics, cancer, agriculture and more. Their reproductive and genetic health portfolio addresses the continuum from preconception to pregnancy to genetic conditions. Products highlighted include VeriSeq PGS for embryo screening, Karyomapping for inherited disorder screening, and their non-invasive prenatal testing solution in development. The NextSeq 550 was also introduced as a platform that enables both sequencing and array scanning applications on a single system.
Illumina-General-Overview-Q1-17
This document is a presentation from Illumina about genomics and their company. It discusses how genome sequencing can provide health insights, their progress in clinical adoption and research use, and their mission to improve human health through genomics. It provides details on Illumina's background, products, markets served, and goals to accelerate genomic adoption and establish new businesses in cancer screening and consumer genomics.
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
The document summarizes the development and validation of a solid-phase competition ELISA (SPC-ELISA) for detecting antibodies to Foot and Mouth Disease Virus type A. The SPC-ELISA uses a recombinant protein derived from a type A FMDV strain and a monoclonal antibody competitor. Testing on panels of vaccinated, infected, and reference sera demonstrated high concordance with virus neutralization tests. The SPC-ELISA had 90.9% sensitivity and 98.3% specificity relative to virus neutralization tests, making it a simple and robust tool to replace virus neutralization tests for FMDV sero-surveillance.
OS20 - Indirect ELISAs based on purified viral particles that measures differ...
The document discusses indirect ELISAs based on purified viral particles that can measure different aspects of the antibody response as alternatives to currently used serological methods for FMDV. It describes assessing 146S-ELISAs that measure IgG-subtypes and avidity of vaccine-induced antibodies as surrogates of the virus neutralization test in pigs, buffaloes, and cattle. The study looked at 530 pigs, 58 buffaloes, and 108 cattle.
OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...
This document summarizes research on using a filtration assisted luminometric ELISA (FAL-ELISA) to detect foot-and-mouth disease virus (FMDV) non-structural proteins in formulated vaccines as an alternative to animal testing. The researchers were able to extract the FMDV 3B protein from the aqueous phase of spiked FMDV-oil vaccines using FAL-ELISA. This demonstrates the feasibility of detecting FMDV non-structural proteins in formulated vaccines with FAL-ELISA. The researchers conclude that FAL-ELISA is a promising candidate to replace animal testing for quality control of FMD vaccines, which could be useful for vaccine banks and regulatory bodies.
SLAS Ultra-High-Throughput Screening Special Interest Group SLAS2017 Presenta...
SLAS Ultra-High-Throughput Screening Special Interest Group SLAS2017 Presenta...SLAS (Society for Laboratory Automation and Screening)
Timothy Dawes of Genentech and Elliot Hui of the University of California, Irvine share their well-received presentation from SLAS2017 in Washington, DC. SLAS Screen Design and Assay Technology Special Interest Group SLAS2017 Prese...
SLAS Screen Design and Assay Technology Special Interest Group SLAS2017 Prese...SLAS (Society for Laboratory Automation and Screening)
Adam Weinglass and Mary Jo Wildey from Merck & Co. share their winning presentation from SLAS2017 in Washington, DC. Join the conversation in the SLAS Screen Design and Assay Technology Special Interest Group LinkedIn group at https://www.linkedin.com/groups/3867725.Poster
At the 247th ACS National Meeting in Dallas, TX from March 16-18, 2014, Chang Zhang and Bang-Ce Ye from the State Key Laboratory of Bioreactor Engineering presented work on developing genetically-encoded fluorescent biosensors to quantitatively monitor levels of the metabolite 2-oxoglutarate (2OG) in cells. They designed two types of biosensors using 2OG-binding domains fused to fluorescent proteins or FRET pairs. Testing showed the sensors were selective for 2OG and responded linearly to concentration changes both in vitro and in vivo. Using the sensors, they monitored real-time 2OG dynamics in E. coli cells under metabolic challenges. The 2OG biosensors provide a tool for studying carbon
Who owns CRISPR? - An update on the Interference.
Here is a brief discussion of this important technology and the legal dispute before the USPTO about rights to the technology
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...Oncomine Precision Oncology - Thermo Fisher Scientific
In this presentation we showcase the latest advancements in myeloid genomic profiling: The Ion Torrent Oncomine Myeloid Assay GX.
Learn how this solution addresses key challenges in myeloid molecular testing and see recent data from the University of Pennsylvania.
Learn more at www.oncomine.com/myeloidPRODUCTION OF YELLOW FEVER VIRUS IN VERO CELLS GROWN IN SERUM-FREE MEDIUM
This document summarizes research on producing yellow fever virus in Vero cells grown in serum-free medium. The researchers were able to obtain very high virus titers of 108 pfu/mL using the best conditions for cell propagation and viral infection in serum-free medium. Analysis showed no difference in antigenic properties between virus cultivated in serum-containing and serum-free medium. SDS-PAGE analysis confirmed a drastic reduction in protein content for yellow fever virus cultivated in serum-free medium. Developing a cell culture process for propagating yellow fever virus in serum-free Vero cells could be an important step towards producing a new inactivated yellow fever vaccine.
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
Researchers from the National Animal and Plant Quarantine Agency in South Korea developed and validated a new recombinant protein-based ELISA for detecting antibodies to foot-and-mouth disease virus type O. They tested the ELISA on over 1,700 field sera samples from cattle and pigs, as well as international reference sera, and found it had an overall diagnostic specificity of 99.9% and sensitivity of 95.2%. The recombinant protein used in the ELISA was derived from a baculovirus-expressed FMDV type O strain. The ELISA demonstrated high serotype specificity, reproducibility, and stability, making it a useful new tool for foot-and-mouth disease surveillance and control.
OS20 - Enhanced complete genome sequencing of foot-and-mouth disease virus us...
This document describes a method for enhancing complete genome sequencing of foot-and-mouth disease virus (FMDV) using probe enrichment of next generation sequencing libraries. The method involves creating a library of oligonucleotide probes to enrich sequencing libraries for FMDV sequences prior to sequencing. This target enrichment was shown to dramatically improve the depth of coverage achieved for FMDV sequencing, increasing coverage over 100-fold for good quality samples and enabling sequencing of much weaker samples and samples subjected to heat denaturing. Target enrichment also allowed obtaining a complete FMDV genome from an RNA sample extracted from a field swab in an African abattoir.
Using film in schools
This document provides a guide for using film in schools, covering several areas:
- Film can be used across many subjects to engage students, from using clips to stimulate writing to making documentaries in history.
- Both film viewing and filmmaking can be done manageably with basic equipment and short projects.
- Film contributes to broader outcomes like improving behavior, attendance, and building workplace skills.
- The guide offers advice on procurement, spaces, legal issues, and partners for film education.
Npi with bpm webinar
The document discusses using SAP BPM to streamline new product introduction processes. It describes challenges with current manual processes that involve coordination across multiple countries and entities. SAP BPM can help by modeling the new product process, automatically assigning tasks, integrating with SAP systems, and providing visibility and control over the end-to-end process. Key benefits of using SAP BPM include reduced cycle times, increased efficiency, improved data quality, and greater transparency.
More Related Content
What's hot
Bacterial Pathogen Genomics at NCBI
"Bacterial Pathogen Genomics at NCBI" presentation at the Standards for Pathogen Identification via NGS (SPIN) workshop hosted by National Institute for Standards and Technology October 2014 by Dr. Bill Klimke.
Viral ER Presentation (1)
This document summarizes a project aiming to decrease viral virulence through reverse evolution. The project will passage viruses multiple times in host cells expressing a viral protein to induce loss of function mutations. If viruses lose ability to produce the supplemented protein, they may become replication deficient. Experiments are examining influenza A virus passage in cells expressing the M1 protein over multiple generations to induce loss of function mutations through viral adaptation. Optimization of cell culture and molecular techniques like qPCR are improving the model. Future work will sequence evolved viruses to analyze genetic changes and their effects on function.
Oncomine Myeloid GX NGS Solution Infographic
The document summarizes the Oncomine Myeloid Assay GX, a one-day genomic profiling assay for myeloid samples. It provides automated specimen-to-report workflow including library preparation, sequencing, variant calling, and reporting. The assay can simultaneously interrogate DNA mutations and RNA fusion transcripts covering major myeloid disorders. It has high gene coverage, detects challenging targets, and provides an annotated variant report.
OS20 - Avidity ELISA provides a good correlate with the virus neutralization ...
The avidity ELISA provides a good correlate with the virus neutralization test in assessing vaccine-induced antibodies in buffaloes. The study developed a single dilution avidity ELISA to measure FMD vaccine antibodies in buffaloes and compared it to standard tests like virus neutralization tests and liquid phase blocking ELISA. Results showed substantial concordance between the avidity ELISA and virus neutralization test, while the liquid phase blocking ELISA only had moderate concordance. The avidity ELISA and virus neutralization test also similarly detected a decrease in antibody levels of calves with maternal antibodies, which was significantly different at specific time points post-vaccination. The avidity ELISA provides a simple, specific technique that could replace the virus neutralization test for monitoring vaccine
Application of Whole Genome Sequencing in the infectious disease’ in vitro di...
This document discusses the application of whole genome sequencing in infectious disease diagnostics. It provides examples of how genome sequencing has been used to identify bacterial species, detect antibiotic resistance genes, and study outbreaks. The document also discusses challenges around regulatory approval of genomic tests, data sharing policies, and database management. Overall, it argues that whole genome sequencing is a valuable tool but that standards must be developed to ensure high quality data.
Transgenic mice service
Since the first EGFR targeting antibody panitumumab (Vectibix) from humanized mice has obtained regulatory approval in 2005, dozens of additional transgenic mouse-derived mAbs have entered human clinical testing, i.e., CD20 (Ofatumumab), CD4 (Zanolimumab), CD70, etc. These genetically "humanized" animals have become one of the most powerful strategies for therapeutic/ diagnostic antibody development, which is now the fastest growing group of mAb drugs in clinical trials currently.
DGR Technology Platform for Engineering Proteins Advanced in Publication by A...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--AvidBiotics today announced the publication of new fin...
I Jornada Actualización en Genética Reproductiva y Fertilidad
Illumina is a global leader in genomic technologies that provides sequencing and microarray solutions. Their portfolio includes the MiSeq, NextSeq 500, HiSeq 2500, and HiSeq X Ten sequencing platforms. Illumina serves customers in human health, research, reproductive health, forensics, cancer, agriculture and more. Their reproductive and genetic health portfolio addresses the continuum from preconception to pregnancy to genetic conditions. Products highlighted include VeriSeq PGS for embryo screening, Karyomapping for inherited disorder screening, and their non-invasive prenatal testing solution in development. The NextSeq 550 was also introduced as a platform that enables both sequencing and array scanning applications on a single system.
Illumina-General-Overview-Q1-17
This document is a presentation from Illumina about genomics and their company. It discusses how genome sequencing can provide health insights, their progress in clinical adoption and research use, and their mission to improve human health through genomics. It provides details on Illumina's background, products, markets served, and goals to accelerate genomic adoption and establish new businesses in cancer screening and consumer genomics.
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
The document summarizes the development and validation of a solid-phase competition ELISA (SPC-ELISA) for detecting antibodies to Foot and Mouth Disease Virus type A. The SPC-ELISA uses a recombinant protein derived from a type A FMDV strain and a monoclonal antibody competitor. Testing on panels of vaccinated, infected, and reference sera demonstrated high concordance with virus neutralization tests. The SPC-ELISA had 90.9% sensitivity and 98.3% specificity relative to virus neutralization tests, making it a simple and robust tool to replace virus neutralization tests for FMDV sero-surveillance.
OS20 - Indirect ELISAs based on purified viral particles that measures differ...
The document discusses indirect ELISAs based on purified viral particles that can measure different aspects of the antibody response as alternatives to currently used serological methods for FMDV. It describes assessing 146S-ELISAs that measure IgG-subtypes and avidity of vaccine-induced antibodies as surrogates of the virus neutralization test in pigs, buffaloes, and cattle. The study looked at 530 pigs, 58 buffaloes, and 108 cattle.
OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...
This document summarizes research on using a filtration assisted luminometric ELISA (FAL-ELISA) to detect foot-and-mouth disease virus (FMDV) non-structural proteins in formulated vaccines as an alternative to animal testing. The researchers were able to extract the FMDV 3B protein from the aqueous phase of spiked FMDV-oil vaccines using FAL-ELISA. This demonstrates the feasibility of detecting FMDV non-structural proteins in formulated vaccines with FAL-ELISA. The researchers conclude that FAL-ELISA is a promising candidate to replace animal testing for quality control of FMD vaccines, which could be useful for vaccine banks and regulatory bodies.
SLAS Ultra-High-Throughput Screening Special Interest Group SLAS2017 Presenta...
SLAS Ultra-High-Throughput Screening Special Interest Group SLAS2017 Presenta...SLAS (Society for Laboratory Automation and Screening)
Timothy Dawes of Genentech and Elliot Hui of the University of California, Irvine share their well-received presentation from SLAS2017 in Washington, DC. SLAS Screen Design and Assay Technology Special Interest Group SLAS2017 Prese...
SLAS Screen Design and Assay Technology Special Interest Group SLAS2017 Prese...SLAS (Society for Laboratory Automation and Screening)
Adam Weinglass and Mary Jo Wildey from Merck & Co. share their winning presentation from SLAS2017 in Washington, DC. Join the conversation in the SLAS Screen Design and Assay Technology Special Interest Group LinkedIn group at https://www.linkedin.com/groups/3867725.Poster
At the 247th ACS National Meeting in Dallas, TX from March 16-18, 2014, Chang Zhang and Bang-Ce Ye from the State Key Laboratory of Bioreactor Engineering presented work on developing genetically-encoded fluorescent biosensors to quantitatively monitor levels of the metabolite 2-oxoglutarate (2OG) in cells. They designed two types of biosensors using 2OG-binding domains fused to fluorescent proteins or FRET pairs. Testing showed the sensors were selective for 2OG and responded linearly to concentration changes both in vitro and in vivo. Using the sensors, they monitored real-time 2OG dynamics in E. coli cells under metabolic challenges. The 2OG biosensors provide a tool for studying carbon
Who owns CRISPR? - An update on the Interference.
Here is a brief discussion of this important technology and the legal dispute before the USPTO about rights to the technology
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...Oncomine Precision Oncology - Thermo Fisher Scientific
In this presentation we showcase the latest advancements in myeloid genomic profiling: The Ion Torrent Oncomine Myeloid Assay GX.
Learn how this solution addresses key challenges in myeloid molecular testing and see recent data from the University of Pennsylvania.
Learn more at www.oncomine.com/myeloidPRODUCTION OF YELLOW FEVER VIRUS IN VERO CELLS GROWN IN SERUM-FREE MEDIUM
This document summarizes research on producing yellow fever virus in Vero cells grown in serum-free medium. The researchers were able to obtain very high virus titers of 108 pfu/mL using the best conditions for cell propagation and viral infection in serum-free medium. Analysis showed no difference in antigenic properties between virus cultivated in serum-containing and serum-free medium. SDS-PAGE analysis confirmed a drastic reduction in protein content for yellow fever virus cultivated in serum-free medium. Developing a cell culture process for propagating yellow fever virus in serum-free Vero cells could be an important step towards producing a new inactivated yellow fever vaccine.
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
Researchers from the National Animal and Plant Quarantine Agency in South Korea developed and validated a new recombinant protein-based ELISA for detecting antibodies to foot-and-mouth disease virus type O. They tested the ELISA on over 1,700 field sera samples from cattle and pigs, as well as international reference sera, and found it had an overall diagnostic specificity of 99.9% and sensitivity of 95.2%. The recombinant protein used in the ELISA was derived from a baculovirus-expressed FMDV type O strain. The ELISA demonstrated high serotype specificity, reproducibility, and stability, making it a useful new tool for foot-and-mouth disease surveillance and control.
OS20 - Enhanced complete genome sequencing of foot-and-mouth disease virus us...
This document describes a method for enhancing complete genome sequencing of foot-and-mouth disease virus (FMDV) using probe enrichment of next generation sequencing libraries. The method involves creating a library of oligonucleotide probes to enrich sequencing libraries for FMDV sequences prior to sequencing. This target enrichment was shown to dramatically improve the depth of coverage achieved for FMDV sequencing, increasing coverage over 100-fold for good quality samples and enabling sequencing of much weaker samples and samples subjected to heat denaturing. Target enrichment also allowed obtaining a complete FMDV genome from an RNA sample extracted from a field swab in an African abattoir.
What's hot (20)
OS20 - Avidity ELISA provides a good correlate with the virus neutralization ...
OS20 - Avidity ELISA provides a good correlate with the virus neutralization ...
Application of Whole Genome Sequencing in the infectious disease’ in vitro di...
Application of Whole Genome Sequencing in the infectious disease’ in vitro di...
DGR Technology Platform for Engineering Proteins Advanced in Publication by A...
DGR Technology Platform for Engineering Proteins Advanced in Publication by A...
I Jornada Actualización en Genética Reproductiva y Fertilidad
I Jornada Actualización en Genética Reproductiva y Fertilidad
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Indirect ELISAs based on purified viral particles that measures differ...
OS20 - Indirect ELISAs based on purified viral particles that measures differ...
OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...
OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...
SLAS Ultra-High-Throughput Screening Special Interest Group SLAS2017 Presenta...
SLAS Ultra-High-Throughput Screening Special Interest Group SLAS2017 Presenta...
SLAS Screen Design and Assay Technology Special Interest Group SLAS2017 Prese...
SLAS Screen Design and Assay Technology Special Interest Group SLAS2017 Prese...
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
PRODUCTION OF YELLOW FEVER VIRUS IN VERO CELLS GROWN IN SERUM-FREE MEDIUM
PRODUCTION OF YELLOW FEVER VIRUS IN VERO CELLS GROWN IN SERUM-FREE MEDIUM
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
OS20 - Enhanced complete genome sequencing of foot-and-mouth disease virus us...
OS20 - Enhanced complete genome sequencing of foot-and-mouth disease virus us...
Viewers also liked
Using film in schools
This document provides a guide for using film in schools, covering several areas:
- Film can be used across many subjects to engage students, from using clips to stimulate writing to making documentaries in history.
- Both film viewing and filmmaking can be done manageably with basic equipment and short projects.
- Film contributes to broader outcomes like improving behavior, attendance, and building workplace skills.
- The guide offers advice on procurement, spaces, legal issues, and partners for film education.
Npi with bpm webinar
The document discusses using SAP BPM to streamline new product introduction processes. It describes challenges with current manual processes that involve coordination across multiple countries and entities. SAP BPM can help by modeling the new product process, automatically assigning tasks, integrating with SAP systems, and providing visibility and control over the end-to-end process. Key benefits of using SAP BPM include reduced cycle times, increased efficiency, improved data quality, and greater transparency.
Literacy moves on
This document discusses the changing nature of literacy in the 21st century. It notes that children's interests are increasingly focused on popular culture through activities like watching TV, playing video games, and engaging with toys and movies. It also discusses how new technologies are influencing and changing literacy practices as children adopt digital literacies. The definition of "text" is expanding to include multimodal forms of communication beyond just printed words. Schools are challenged to integrate children's out-of-school interests into the curriculum and help children develop critical perspectives on the texts they engage with.
Using digital-and-multimodal-texts(1)
This document provides guidance for teachers on using digital and multimodal texts in K-6 English classrooms based on the NSW English K-10 syllabus. It defines digital and multimodal texts and explains how reading these texts differs from reading traditional print texts. The document explores examples of digital texts and outlines how teachers can plan lessons incorporating these texts. It also identifies relevant syllabus outcomes and provides additional resources for teachers.
Microsoft azureとdockerとansibleと
Microsoft Azure上のDocker on Ubuntu ServerにAbnsibleとDocker Composeを利用して、バージョンが異なるPHP環境をコンテナごとに構築＆ アプケーションテスト自動化を目指したのですが、うまくいかなかった点やつまづいたところについて発表させていただきました。
Chak de india
This document discusses the key leadership qualities and strategies that were important for India's national women's hockey team to win. It emphasizes that having the right leader who treats all team members fairly and helps them realize their potential is crucial. It also stresses the importance of having the right attitude, positive body language, prioritizing the team over individual goals, knowing your opponents' strengths and weaknesses, and working together toward a common goal of winning. The overall message is that strong leadership, teamwork, strategy, and perseverance can make the impossible possible.
Multimodal presentation by_claire_thickett
This document provides information about composing multimodal texts. It defines what multimodal texts and semiotic systems are. It explains that multimodal texts convey meaning through a combination of elements that draw upon several semiotic systems, including linguistic, visual, gestural, audio, and spatial. It also discusses the four roles of the reader - code breaker, meaning maker, text user, and text analyst. Finally, it defines the three main types of texts - imaginative, informative, and persuasive - and provides examples of each.
Viewers also liked (8)
Similar to Sara restrepo (3)
ELISA TEST
The document discusses several ways that ELISA tests can be used to detect proteins and antibodies in blood samples. It describes a study that found high levels of the DEK gene in plasma are correlated with better outcomes for head and neck cancer patients. The document also summarizes the development of a new type of simple test strip that can detect blood proteins with high precision and may have applications for disease diagnosis, food/drug testing, and environmental monitoring.
See the Whole Picture: Using SV-AUC for Empty/Full AAV Capsid Analysis
Watch this webinar here: https://bit.ly/31ZZM3n
Join this webinar for key insights on using the SV-AUC assay for empty/full analysis of your AAV viral vector. We’ll cover the technical requirements for this assay, data interpretation, and finally how this assay fits into the larger picture of AAV characterization.
Recombinant adeno-associated viruses (AAV) are widely used as gene transfer vectors. However, AAV production generates mixed populations of viral capsids containing either complete viral vector genome (full capsids); partially filled, and those lacking the viral genome (empty capsids). Sedimentation Velocity Analytical Ultracentrifugation (SV-AUC) offers a robust, accurate, and consistent method for characterizing empty/full AAV capsid composition. In this webinar we will review the key technical requirements for performing an AUC assay as well as analysis and data interpretation of the results generated.
In this webinar, you will learn:
• Regulatory expectations for empty/full analysis
• Key technical requirements for running an AUC assay and how to interpret the data from the results generated
• How the AUC assay fits into the larger picture of AAV characterization
See the Whole Picture: Using SV-AUC for Empty/Full AAV Capsid Analysis
Regulatory agencies require characterization of AAV particle composition, including measurement of empty and full capsids. Analytical ultracentrifugation (AUC) provides a method to determine the percentage of empty, partial, and full capsids in a sample and fits into a multi-method approach to characterize identity, purity, biological activity, and safety of gene therapy products. Monitoring product impurities such as empty particles decreases safety risks.
Application Brief: Abdominal Aortic Aneurysm
Abdominal Aortic Aneurysm (AAA) is a serious and potentially fatal disease that is prevalent in the older population. Scientists are making use of animal models to study the progression of this disease and the effects of therapeutic interventions over longitudinal studies.
BILS 2015 Genethon M. Hebben
BILS 2015 Genethon
"Debottlenecking Downstream Process of AAV9 Gene Therapy Vectors using Customized Chromatography Resin"
Matthias Hebben, Ph.D. Bioprocess Development
ABPI Conference 2016 - Dr Mene Pangalos on 'Driving innovation in the R&D Eco...
ABPI Conference 2016 - Dr Mene Pangalos on 'Driving innovation in the R&D Eco...Association of the British Pharmaceutical Industry (ABPI)
This document discusses AstraZeneca's efforts to drive innovation in its R&D ecosystem. It provides a case study on the development of the drug osimertinib for lung cancer. Osimertinib was designed using structure-based drug design to target the T790M mutation involved in resistance to earlier EGFR inhibitors. It achieved rapid approval timelines of around 3 years from discovery to approval. The document also discusses AstraZeneca's focus on areas like oncology, cardiovascular disease, and immunology. It emphasizes approaches like using biotech hubs, open innovation, talent development, and new technologies to advance personalized healthcare and reshape the company's pipeline.JALANov2000
This document provides an overview of the November 2000 issue of JALA (Journal of Analytical Laboratories Automation). It describes the development of a novel robotic system for the New York Cancer Project biorepository in collaboration with the Medical Automation Research Center. The biorepository receives 50-100 blood samples per day which are processed robotically to extract, quantify, aliquot and store DNA, plasma and RNA to be accessible to investigators. The robotic system aims to provide rapid random access to the hundreds of thousands of DNA samples stored for high-throughput analysis in studies of gene-environment interactions and cancer risk.
2020 09-07 European Center Pharmaceutical Medicine course Biomarkers, Basel, ...
Tutorial lecture on biomarkers for pharmaceutical industry R&D professionals, outlining status, potential and challenges of biomarkers in pharma, clinic and society.
Full Thesis
This document describes the development of a new diagnostic method called ProteAl for the rapid detection of Proteus bacteria. 2-methylbutanal was identified as a volatile organic compound biomarker specifically produced by Proteus. A fluorescent assay was developed using the reagent 5-dimethylaminonaphthalene-1-sulfonylhydrazine to detect 2-methylbutanal. This ProteAl assay could identify Proteus within 7 hours of growth and differentiated it from other common uropathogens. The production of 2-methylbutanal by Proteus was found to be regulated by the isoleucine metabolic pathway. Rational design of growth medium with increased isoleucine enhanced the yield of
Bacterial typing idse14_wm
The introduction of new molecular diagnostic technologies is transforming clinical microbiology testing by providing faster results compared to traditional culture-based methods. These technologies like PCR, mass spectrometry, and next-generation sequencing can provide results in hours rather than days. Earlier diagnostic information from these tests has been shown to improve patient outcomes. Many laboratories are evaluating how to incorporate molecular testing while reducing reliance on culture-based methods. These new tests are also being applied to infection control practice to help with tasks like surveillance and isolation precautions.
Subclinical Infections and Male Infertility
The document discusses subclinical male genital tract infections (MAGI) and their relationship to male infertility. It notes that MAGI may decrease fertility by increasing oxidative stress through reactive oxygen species produced by leukocytes in the semen. While antibiotic therapy is suggested for treating MAGI, the effect on fertility is still unclear. The document recommends focusing on identifying the source of increased reactive oxygen species and treating with antioxidants to help address MAGI's negative impacts on fertility through oxidative stress.
Array_nmeth.3507
This document describes an automated robotic platform developed for the high-throughput production of induced pluripotent stem cells (iPSCs) with minimal manual intervention. Some key points:
- The platform automates the reprogramming of skin fibroblasts into iPSCs using mRNA, as well as purification of iPSCs using immunomagnetic beads to isolate TRA-1-60+ cells.
- Automated reprogramming resulted in the generation of over 200 iPSC lines from adult fibroblasts with a reprogramming efficiency of 0.001-0.16%. A modified reprogramming strategy using gradual serum reduction improved success rates.
- Polyclonal iPSC lines produced through the automated process expressed plurip
Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...
Inger Mollerup, Vice President of Novo Nordisk A/S, testified before the Government Oversight and Reform Committee about establishing a pathway for approval of follow-on biologics. She argued that any pathway must require clinical trials to demonstrate safety because even minor differences in biologics can have major health consequences, as shown through Novo Nordisk's experience. She also stated that traceability and unique names are important for pharmacovigilance, and that interchangeability is not supported by current science given potential immunogenicity differences between products.
APPLICATIONS of Biotechnology
Biotechnology is the use of living organisms to develop useful products. Modern biotechnology techniques include isolating DNA, inserting genes into vectors, and transforming host cells. Applications include producing Bt crops for pest resistance, producing vaccines and diagnosing diseases. New advances include artificial lymph nodes, non-invasive cancer detection from saliva, smart contact lenses to monitor eye pressure, and machines that can scan the liver non-invasively. Biotechnology continues to progress rapidly with applications in agriculture, medicine, and other fields.
2016-12-10 eJIFCC Vol27No4
This document summarizes an editorial on recent advances in the clinical application of mass spectrometry. It discusses how liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) and inductively coupled plasma mass spectrometry (ICP-MS) have expanded the use of mass spectrometry in clinical chemistry testing over the past decade. The editorial notes that many clinical chemistry laboratories now use electrospray ionization LC-MS/MS and that external quality assurance programs include more analytes quantified by mass spectrometry methods. While mass spectrometry offers improvements in specificity and sensitivity, some debate remains around its use in clinical laboratories.
Journal of Laboratory Automation-2016-Cain-Hom-37-48
This document summarizes the use of acoustic droplet ejection (ADE) liquid handling systems for genotyping genetically engineered mouse models. Key points:
- Traditional liquid handling robots are limited by low throughput, reproducibility issues, and cross-contamination risks. ADE provides contact-free liquid transfer at much higher speeds and precision.
- The authors integrated an ADE system into their workflow for PCR and qPCR reactions, allowing analysis of complex genetic models. ADE increased throughput by 8-10x compared to traditional robots.
- Testing showed ADE greatly improved data reproducibility and consistency for qPCR, while virtually eliminating cross-contamination risks. It also reduced reagent volumes for significant cost savings.
Tero-Pekka Alastalo - Blueprint Genetics - Stanford Engineering - Jan 4 2016
Talk by Tero-Pekka Alastalo, CEO - Blueprint Genetics (FI), at Stanford on Jan 4 2016, in our session on 'European Startup Bridges in Silicon Valley'.
Website: http://www.StanfordEuropreneurs.org
YouTube Channel: https://www.youtube.com/user/StanfordEuropreneurs
Twitter: @Europreneurs
Prostatic artery embolization
This document discusses building a practice for prostate artery embolization (PAE). It describes establishing a PAE team in 2012 and promoting the technique through an interventional radiology clinic, media outlets like newspapers and TV, and a website. The document outlines the speaker's PAE protocol and technique, and presents results from their first 22 cases, showing improvements in IPSS, prostate volume, and urinary flow rates post-procedure with only minor complications. It concludes that PAE is a feasible, safe, and effective technique that could replace TURP procedures but remains challenging, and greater promotion is needed to increase awareness and support for the technique.
Application Brief - Breast Cancer Research
Breast cancer research in animal models has long been hindered by the lack of a fast, portable, high resolution, research and animal focused imaging system that can visualize 2D tumor size, 3D tumor volume, neoangiogenesis and blood perfusion in vivo, in real-time and most importantly, non-invasively.
EpiGene request for partnership
Early cancer detection kits provide epigenetic PCR tests for screening and early detection of colon, lung, breast and stomach cancers. The developer, EpiGene LLC, is seeking a partnership to enter global markets. Their novel GLAD-PCR assay method allows for quick, sensitive and affordable epigenetic cancer diagnostics using DNA methylation markers. Clinical trials in Russia will evaluate their tests for lung, breast and stomach cancers, having already achieved 97% accuracy for colon cancer detection.
Similar to Sara restrepo (3) (20)
See the Whole Picture: Using SV-AUC for Empty/Full AAV Capsid Analysis
See the Whole Picture: Using SV-AUC for Empty/Full AAV Capsid Analysis
See the Whole Picture: Using SV-AUC for Empty/Full AAV Capsid Analysis
See the Whole Picture: Using SV-AUC for Empty/Full AAV Capsid Analysis
ABPI Conference 2016 - Dr Mene Pangalos on 'Driving innovation in the R&D Eco...
ABPI Conference 2016 - Dr Mene Pangalos on 'Driving innovation in the R&D Eco...
2020 09-07 European Center Pharmaceutical Medicine course Biomarkers, Basel, ...
2020 09-07 European Center Pharmaceutical Medicine course Biomarkers, Basel, ...
Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...
Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...
Journal of Laboratory Automation-2016-Cain-Hom-37-48
Journal of Laboratory Automation-2016-Cain-Hom-37-48
Tero-Pekka Alastalo - Blueprint Genetics - Stanford Engineering - Jan 4 2016
Tero-Pekka Alastalo - Blueprint Genetics - Stanford Engineering - Jan 4 2016
Recently uploaded
Climate Impact of Software Testing at Nordic Testing Days
My slides at Nordic Testing Days 6.6.2024
Climate impact / sustainability of software testing discussed on the talk. ICT and testing must carry their part of global responsibility to help with the climat warming. We can minimize the carbon footprint but we can also have a carbon handprint, a positive impact on the climate. Quality characteristics can be added with sustainability, and then measured continuously. Test environments can be used less, and in smaller scale and on demand. Test techniques can be used in optimizing or minimizing number of tests. Test automation can be used to speed up testing.
GraphSummit Singapore | The Future of Agility: Supercharging Digital Transfor...
Leonard Jayamohan, Partner & Generative AI Lead, Deloitte
This keynote will reveal how Deloitte leverages Neo4j’s graph power for groundbreaking digital twin solutions, achieving a staggering 100x performance boost. Discover the essential role knowledge graphs play in successful generative AI implementations. Plus, get an exclusive look at an innovative Neo4j + Generative AI solution Deloitte is developing in-house.
Microsoft - Power Platform_G.Aspiotis.pdf
Revolutionizing Application Development
with AI-powered low-code, presentation by George Aspiotis, Sr. Partner Development Manager, Microsoft
20240607 QFM018 Elixir Reading List May 2024
Everything I found interesting about the Elixir programming ecosystem in May 2024
UiPath Test Automation using UiPath Test Suite series, part 5
Welcome to UiPath Test Automation using UiPath Test Suite series part 5. In this session, we will cover CI/CD with devops.
Topics covered:
CI/CD with in UiPath
End-to-end overview of CI/CD pipeline with Azure devops
Speaker:
Lyndsey Byblow, Test Suite Sales Engineer @ UiPath, Inc.
Driving Business Innovation: Latest Generative AI Advancements & Success Story
Are you ready to revolutionize how you handle data? Join us for a webinar where we’ll bring you up to speed with the latest advancements in Generative AI technology and discover how leveraging FME with tools from giants like Google Gemini, Amazon, and Microsoft OpenAI can supercharge your workflow efficiency.
During the hour, we’ll take you through:
Guest Speaker Segment with Hannah Barrington: Dive into the world of dynamic real estate marketing with Hannah, the Marketing Manager at Workspace Group. Hear firsthand how their team generates engaging descriptions for thousands of office units by integrating diverse data sources—from PDF floorplans to web pages—using FME transformers, like OpenAIVisionConnector and AnthropicVisionConnector. This use case will show you how GenAI can streamline content creation for marketing across the board.
Ollama Use Case: Learn how Scenario Specialist Dmitri Bagh has utilized Ollama within FME to input data, create custom models, and enhance security protocols. This segment will include demos to illustrate the full capabilities of FME in AI-driven processes.
Custom AI Models: Discover how to leverage FME to build personalized AI models using your data. Whether it’s populating a model with local data for added security or integrating public AI tools, find out how FME facilitates a versatile and secure approach to AI.
We’ll wrap up with a live Q&A session where you can engage with our experts on your specific use cases, and learn more about optimizing your data workflows with AI.
This webinar is ideal for professionals seeking to harness the power of AI within their data management systems while ensuring high levels of customization and security. Whether you're a novice or an expert, gain actionable insights and strategies to elevate your data processes. Join us to see how FME and AI can revolutionize how you work with data!
Goodbye Windows 11: Make Way for Nitrux Linux 3.5.0!
As the digital landscape continually evolves, operating systems play a critical role in shaping user experiences and productivity. The launch of Nitrux Linux 3.5.0 marks a significant milestone, offering a robust alternative to traditional systems such as Windows 11. This article delves into the essence of Nitrux Linux 3.5.0, exploring its unique features, advantages, and how it stands as a compelling choice for both casual users and tech enthusiasts.
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Discover the seamless integration of RPA (Robotic Process Automation), COMPOSER, and APM with AWS IDP enhanced with Slack notifications. Explore how these technologies converge to streamline workflows, optimize performance, and ensure secure access, all while leveraging the power of AWS IDP and real-time communication via Slack notifications.
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAU
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-und-domino-lizenzkostenreduzierung-in-der-welt-von-dlau/
DLAU und die Lizenzen nach dem CCB- und CCX-Modell sind für viele in der HCL-Community seit letztem Jahr ein heißes Thema. Als Notes- oder Domino-Kunde haben Sie vielleicht mit unerwartet hohen Benutzerzahlen und Lizenzgebühren zu kämpfen. Sie fragen sich vielleicht, wie diese neue Art der Lizenzierung funktioniert und welchen Nutzen sie Ihnen bringt. Vor allem wollen Sie sicherlich Ihr Budget einhalten und Kosten sparen, wo immer möglich. Das verstehen wir und wir möchten Ihnen dabei helfen!
Wir erklären Ihnen, wie Sie häufige Konfigurationsprobleme lösen können, die dazu führen können, dass mehr Benutzer gezählt werden als nötig, und wie Sie überflüssige oder ungenutzte Konten identifizieren und entfernen können, um Geld zu sparen. Es gibt auch einige Ansätze, die zu unnötigen Ausgaben führen können, z. B. wenn ein Personendokument anstelle eines Mail-Ins für geteilte Mailboxen verwendet wird. Wir zeigen Ihnen solche Fälle und deren Lösungen. Und natürlich erklären wir Ihnen das neue Lizenzmodell.
Nehmen Sie an diesem Webinar teil, bei dem HCL-Ambassador Marc Thomas und Gastredner Franz Walder Ihnen diese neue Welt näherbringen. Es vermittelt Ihnen die Tools und das Know-how, um den Überblick zu bewahren. Sie werden in der Lage sein, Ihre Kosten durch eine optimierte Domino-Konfiguration zu reduzieren und auch in Zukunft gering zu halten.
Diese Themen werden behandelt
- Reduzierung der Lizenzkosten durch Auffinden und Beheben von Fehlkonfigurationen und überflüssigen Konten
- Wie funktionieren CCB- und CCX-Lizenzen wirklich?
- Verstehen des DLAU-Tools und wie man es am besten nutzt
- Tipps für häufige Problembereiche, wie z. B. Team-Postfächer, Funktions-/Testbenutzer usw.
- Praxisbeispiele und Best Practices zum sofortigen Umsetzen
How to Get CNIC Information System with Paksim Ga.pptx
Pakdata Cf is a groundbreaking system designed to streamline and facilitate access to CNIC information. This innovative platform leverages advanced technology to provide users with efficient and secure access to their CNIC details.
Removing Uninteresting Bytes in Software Fuzzing
Imagine a world where software fuzzing, the process of mutating bytes in test seeds to uncover hidden and erroneous program behaviors, becomes faster and more effective. A lot depends on the initial seeds, which can significantly dictate the trajectory of a fuzzing campaign, particularly in terms of how long it takes to uncover interesting behaviour in your code. We introduce DIAR, a technique designed to speedup fuzzing campaigns by pinpointing and eliminating those uninteresting bytes in the seeds. Picture this: instead of wasting valuable resources on meaningless mutations in large, bloated seeds, DIAR removes the unnecessary bytes, streamlining the entire process.
In this work, we equipped AFL, a popular fuzzer, with DIAR and examined two critical Linux libraries -- Libxml's xmllint, a tool for parsing xml documents, and Binutil's readelf, an essential debugging and security analysis command-line tool used to display detailed information about ELF (Executable and Linkable Format). Our preliminary results show that AFL+DIAR does not only discover new paths more quickly but also achieves higher coverage overall. This work thus showcases how starting with lean and optimized seeds can lead to faster, more comprehensive fuzzing campaigns -- and DIAR helps you find such seeds.
- These are slides of the talk given at IEEE International Conference on Software Testing Verification and Validation Workshop, ICSTW 2022.
Artificial Intelligence for XMLDevelopment
In the rapidly evolving landscape of technologies, XML continues to play a vital role in structuring, storing, and transporting data across diverse systems. The recent advancements in artificial intelligence (AI) present new methodologies for enhancing XML development workflows, introducing efficiency, automation, and intelligent capabilities. This presentation will outline the scope and perspective of utilizing AI in XML development. The potential benefits and the possible pitfalls will be highlighted, providing a balanced view of the subject.
We will explore the capabilities of AI in understanding XML markup languages and autonomously creating structured XML content. Additionally, we will examine the capacity of AI to enrich plain text with appropriate XML markup. Practical examples and methodological guidelines will be provided to elucidate how AI can be effectively prompted to interpret and generate accurate XML markup.
Further emphasis will be placed on the role of AI in developing XSLT, or schemas such as XSD and Schematron. We will address the techniques and strategies adopted to create prompts for generating code, explaining code, or refactoring the code, and the results achieved.
The discussion will extend to how AI can be used to transform XML content. In particular, the focus will be on the use of AI XPath extension functions in XSLT, Schematron, Schematron Quick Fixes, or for XML content refactoring.
The presentation aims to deliver a comprehensive overview of AI usage in XML development, providing attendees with the necessary knowledge to make informed decisions. Whether you’re at the early stages of adopting AI or considering integrating it in advanced XML development, this presentation will cover all levels of expertise.
By highlighting the potential advantages and challenges of integrating AI with XML development tools and languages, the presentation seeks to inspire thoughtful conversation around the future of XML development. We’ll not only delve into the technical aspects of AI-powered XML development but also discuss practical implications and possible future directions.
TrustArc Webinar - 2024 Global Privacy Survey
How does your privacy program stack up against your peers? What challenges are privacy teams tackling and prioritizing in 2024?
In the fifth annual Global Privacy Benchmarks Survey, we asked over 1,800 global privacy professionals and business executives to share their perspectives on the current state of privacy inside and outside of their organizations. This year’s report focused on emerging areas of importance for privacy and compliance professionals, including considerations and implications of Artificial Intelligence (AI) technologies, building brand trust, and different approaches for achieving higher privacy competence scores.
See how organizational priorities and strategic approaches to data security and privacy are evolving around the globe.
This webinar will review:
- The top 10 privacy insights from the fifth annual Global Privacy Benchmarks Survey
- The top challenges for privacy leaders, practitioners, and organizations in 2024
- Key themes to consider in developing and maintaining your privacy program
UiPath Test Automation using UiPath Test Suite series, part 6
Welcome to UiPath Test Automation using UiPath Test Suite series part 6. In this session, we will cover Test Automation with generative AI and Open AI.
UiPath Test Automation with generative AI and Open AI webinar offers an in-depth exploration of leveraging cutting-edge technologies for test automation within the UiPath platform. Attendees will delve into the integration of generative AI, a test automation solution, with Open AI advanced natural language processing capabilities.
Throughout the session, participants will discover how this synergy empowers testers to automate repetitive tasks, enhance testing accuracy, and expedite the software testing life cycle. Topics covered include the seamless integration process, practical use cases, and the benefits of harnessing AI-driven automation for UiPath testing initiatives. By attending this webinar, testers, and automation professionals can gain valuable insights into harnessing the power of AI to optimize their test automation workflows within the UiPath ecosystem, ultimately driving efficiency and quality in software development processes.
What will you get from this session?
1. Insights into integrating generative AI.
2. Understanding how this integration enhances test automation within the UiPath platform
3. Practical demonstrations
4. Exploration of real-world use cases illustrating the benefits of AI-driven test automation for UiPath
Topics covered:
What is generative AI
Test Automation with generative AI and Open AI.
UiPath integration with generative AI
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Essentials of Automations: The Art of Triggers and Actions in FME
In this second installment of our Essentials of Automations webinar series, we’ll explore the landscape of triggers and actions, guiding you through the nuances of authoring and adapting workspaces for seamless automations. Gain an understanding of the full spectrum of triggers and actions available in FME, empowering you to enhance your workspaces for efficient automation.
We’ll kick things off by showcasing the most commonly used event-based triggers, introducing you to various automation workflows like manual triggers, schedules, directory watchers, and more. Plus, see how these elements play out in real scenarios.
Whether you’re tweaking your current setup or building from the ground up, this session will arm you with the tools and insights needed to transform your FME usage into a powerhouse of productivity. Join us to discover effective strategies that simplify complex processes, enhancing your productivity and transforming your data management practices with FME. Let’s turn complexity into clarity and make your workspaces work wonders!
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Discover how MongoDB Atlas and vector search technology can revolutionize your application's search capabilities. This comprehensive presentation covers:
* What is Vector Search?
* Importance and benefits of vector search
* Practical use cases across various industries
* Step-by-step implementation guide
* Live demos with code snippets
* Enhancing LLM capabilities with vector search
* Best practices and optimization strategies
Perfect for developers, AI enthusiasts, and tech leaders. Learn how to leverage MongoDB Atlas to deliver highly relevant, context-aware search results, transforming your data retrieval process. Stay ahead in tech innovation and maximize the potential of your applications.
#MongoDB #VectorSearch #AI #SemanticSearch #TechInnovation #DataScience #LLM #MachineLearning #SearchTechnology
Pushing the limits of ePRTC: 100ns holdover for 100 days
At WSTS 2024, Alon Stern explored the topic of parametric holdover and explained how recent research findings can be implemented in real-world PNT networks to achieve 100 nanoseconds of accuracy for up to 100 days.
“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...
“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...Edge AI and Vision Alliance
For the full video of this presentation, please visit: https://www.edge-ai-vision.com/2024/06/building-and-scaling-ai-applications-with-the-nx-ai-manager-a-presentation-from-network-optix/
Robin van Emden, Senior Director of Data Science at Network Optix, presents the “Building and Scaling AI Applications with the Nx AI Manager,” tutorial at the May 2024 Embedded Vision Summit.
In this presentation, van Emden covers the basics of scaling edge AI solutions using the Nx tool kit. He emphasizes the process of developing AI models and deploying them globally. He also showcases the conversion of AI models and the creation of effective edge AI pipelines, with a focus on pre-processing, model conversion, selecting the appropriate inference engine for the target hardware and post-processing.
van Emden shows how Nx can simplify the developer’s life and facilitate a rapid transition from concept to production-ready applications.He provides valuable insights into developing scalable and efficient edge AI solutions, with a strong focus on practical implementation.Recently uploaded (20)
Climate Impact of Software Testing at Nordic Testing Days
Climate Impact of Software Testing at Nordic Testing Days
GraphSummit Singapore | The Future of Agility: Supercharging Digital Transfor...
GraphSummit Singapore | The Future of Agility: Supercharging Digital Transfor...
UiPath Test Automation using UiPath Test Suite series, part 5
UiPath Test Automation using UiPath Test Suite series, part 5
Driving Business Innovation: Latest Generative AI Advancements & Success Story
Driving Business Innovation: Latest Generative AI Advancements & Success Story
Goodbye Windows 11: Make Way for Nitrux Linux 3.5.0!
Goodbye Windows 11: Make Way for Nitrux Linux 3.5.0!
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAU
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAU
How to Get CNIC Information System with Paksim Ga.pptx
How to Get CNIC Information System with Paksim Ga.pptx
UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6
Essentials of Automations: The Art of Triggers and Actions in FME
Essentials of Automations: The Art of Triggers and Actions in FME
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Pushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 days
“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...
“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...
Sara restrepo (3)
- 1. PROTEINSIMPLE REINVENTS THE WESTERN BLOT and FASTER, SCALABLE METHOD FOR PRODUCING AAV-BASED GENE TRANSFER VECTORS Maria Sarah Restrepo Medicine student
- 2. FOLDING Maria Sarah Restrepo
- 3. FOLDING
- 4. INTRODUCTION A REVOLUTIONARY SYSTEM FOR PROTEIN ANALYSIS, THAT HELPS IN A BETTER WAY, TO UNDERSTAND THE NATURE OF PROTEINS IN DISEASES. NEW METHOD FOR THE STUDIED OF VIRAL VECTORS THAT HAS BEEN DEVELOPED, TO SIMPLIFY EVERY STEP OF THE PROCEDURE.
- 5. PROTEINSIMPLE REINVENTS THE WESTERN BLOT Marketwatch. August 30-2011
- 6. PROTEINSIMPLE REINVENTS THE WESTERN BLOT ProteinSimple today introduced a revolutionary new system for protein analysis, Simon and the Simple Western. The Simple Western is a complete reinvention of the Western Blot, and is truly a historic breakthrough for protein research. For the first time in 30 years, researchers have access to a completely automated, walk-away solution for Western analysis.
- 7. PROTEINSIMPLE REINVENTS THE WESTERN BLOT The Western Blot was invented in 1979 and to this day remains the most frequently used technique for protein characterization. Traditional Westerns require many manual steps using gels, transfer tanks, blots and film, and a single experiment can take up to 24 hours to complete.
- 8. PROTEINSIMPLE REINVENTS THE WESTERN BLOT The Simple Western is a Western with none of the hassle. No messy gels, no transfer tanks, no blots, no imaging and no manual analysis. Simply load your samples into Simon, push a button, walk away and come back a few hours later to fully analyzed data.
- 9. PROTEINSIMPLE REINVENTS THE WESTERN BLOT OBSERVATIONS This revolutionary discovery only proves the magnificent importance of technology in Medicine Procedures. With the Simple Western, researchers not only economice time and Money, but gain a faster and developed way to investigate the Proteins and their influence in some di- seases.
- 10. FASTER, SCALABLE METHOD FOR PRODUCING AAV-BASED GENE TRANSFER VECTORS Science Daily. January 05-2011
- 11. FASTER, SCALABLE METHOD FOR PRODUCING AAV-BASED GENE TRANSFER VECTORS A new, simplified method for producing large amounts of viral vector cassettes capable of shuttling genes into host cells will help advance the promising field of gene therapy as applications move into large animal studies and human clinical trials.
- 12. FASTER, SCALABLE METHOD FOR PRODUCING AAV-BASED GENE TRANSFER VECTORS This new method for creating stable AAV2 producer cell lines overcomes the major drawbacks of the previous method: it requires only a one-step cloning process (instead of multiple cloning steps).
- 13. FASTER, SCALABLE METHOD FOR PRODUCING AAV-BASED GENE TRANSFER VECTORS In addition to being faster and easier, their simplified method offers other important advantages, including the potential to produce high yields of multiple AAV serotypes upon co-infection with a helper adenovirus.
- 14. FASTER, SCALABLE METHOD FOR PRODUCING AAV-BASED GENE TRANSFER VECTORS AAV gene therapy is showing promise in the clinic. Important challenges exist for it to become a commercial product such as scalable manufacturing processes.
- 15. OBSERVATIONS A versatil method like this new one, can be an ex- traodinary and useful tool for the scientific commu- nity, reducing the steps of de older method and be- coming a way to develop the AAV genes therapies, that today have the potential to be a commercial product. FASTER, SCALABLE METHOD FOR PRODUCING AAV-BASED GENE TRANSFER VECTORS
- 17. With the simply Western, is easier to understand the behavior of proteins and everything that tours around them. PROTEINSIMPLE REINVENTS THE WESTERN BLOT
- 18. With the new Method for the stu- dy of AAV gene vector, the scienti- fic community is able to put on the medical market a very important treatment as the AAV gene thera- py with more certain results. FASTER, SCALABLE METHOD FOR PRODUCING AAV-BASED GENE TRANSFER VECTORS
- 19. BIBLIOGRAPHY ProteinSimple Reinvents the Western Blot. Marketwatch [online]. [ref. Agost 30, 2011]. Available online http://www.marketwatch.com/story/protei nsimple-reinvents-the-western-blot-2011- 08-30 Faster, Scalable Method for Producing AAV-Based Gene Transfer Vectors. Science Daily [online]. [ref. January 5, 2011]. Avai- lable online <http://www.sciencedaily.com/releases/2
- 20. THANKS